Currently predicting for Thu, 4 Jun 2026

LLY Prediction Chart

LLY Predictions History

Latest community submissions for LLY.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 27, 2026 $895.26 +1.28% $868.27 X 96.89% 0
Apr 27, 2026 $891.02 +0.80% $868.27 X 97.38% 0
Apr 27, 2026 Bullish $868.27 X 0
Jan 28, 2026 $1,026.96 -1.21% $1,023.80 V 99.69% 5
Jan 28, 2026 $1,031.67 -0.75% $1,023.80 V 99.23% 3
Jan 28, 2026 Bullish $1,023.80 X 0
Jan 27, 2026 $1,050.44 -1.16% $1,039.51 V 98.95% 2
Jan 27, 2026 $1,055.06 -0.72% $1,039.51 V 98.50% 2
Jan 27, 2026 $1,084.11 +2.01% $1,039.51 X 95.71% 0
Jan 14, 2026 $1,065.14 -1.12% $1,073.29 V 99.24% 3
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LLY with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ELI LILLY AND COMPANY
Eli Lilly
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE